Parnell Pharmaceuticals Holdings Ltd (OTCMKTS:PARNF – Get Free Report) shares traded up 120% during trading on Wednesday . The stock traded as high as $0.35 and last traded at $0.11. 57,693 shares were traded during trading, an increase of 25% from the average session volume of 46,273 shares. The stock had previously closed at $0.05.
Parnell Pharmaceuticals Price Performance
Parnell Pharmaceuticals Company Profile
Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal – U.S., Production Animal – Rest of World, and Manufacturing Operations.
Featured Articles
- Five stocks we like better than Parnell Pharmaceuticals
- How is Compound Interest Calculated?
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- Investing in Travel Stocks Benefits
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- The Risks of Owning Bonds
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Parnell Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parnell Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
